Pfizer's second biosimilar of J & J's Remicade wins U.S. FDA approval
(Reuters) - The U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson& Johnson's blockbuster rheumatoid arthritis drug, Remicade, the company said on Wednesday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Arthritis | Food and Drug Administration (FDA) | Health | Pfizer | Remicade | Rheumatoid Arthritis | Rheumatology